In Pakistan, the pharmaceutical intermediate industry faces significant hurdles due to extreme seasonal temperature fluctuations. Traditional oils often degrade under high heat, leading to contamination in sensitive chemical syntheses. This has created an urgent demand for Perfluoropolyether oil which offers unparalleled thermal stability and chemical inertness.
The manufacturing hubs in Karachi and Lahore are increasingly adopting Liquid cooling systems to protect high-value pharmaceutical precursors. The volatility of local power grids also necessitates cooling fluids that can maintain thermal inertia during outages to prevent hazardous runaway reactions in intermediate synthesis.
Furthermore, as Pakistan aligns its pharmaceutical standards with global GMP requirements, the shift toward non-reactive heat transfer fluid has become a strategic priority to ensure batch consistency and reduce the cost of purification processes.
